What is HistoGenetics?
HistoGenetics specializes in sophisticated genetic testing solutions, offering services such as HLA typing, whole genome sequencing, and comprehensive genomic analyses. The company's innovative technologies are crucial for donor registries, pharmacogenomics, transplant centers, and HLA laboratories, delivering high-quality, cost-effective solutions. By leveraging cutting-edge sequencing methods and a robust suite of tissue-typing services, HistoGenetics is dedicated to enhancing precision medicine for healthcare providers, research institutions, and organizations focused on transplantation and immunogenetics.
How much funding has HistoGenetics raised?
HistoGenetics has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in HistoGenetics
PPP
Public-Private Partnership
What's next for HistoGenetics?
The recent major strategic investment positions HistoGenetics for accelerated growth and expanded service offerings. This capital infusion is expected to fuel further research and development into novel sequencing technologies and enhance the company's capacity to support complex genomic analyses. HistoGenetics is poised to deepen its impact on transplant success rates and the broader field of immunogenetics, solidifying its role as a key player in the precision medicine landscape.
See full HistoGenetics company page
